Feature Channels: AIDS and HIV

Filters close
Released: 12-Jan-2024 9:05 PM EST
Nutritional acquired immunodeficiency (N-AIDS) is the leading driver of the TB pandemic
Boston University School of Medicine

Tuberculosis (TB) is the leading infectious killer worldwide, with 10.6 million cases and 1.6 million deaths in 2021 alone. One in five incident TB cases were attributable to malnutrition, more than double the number attributed to HIV/AIDS.

Released: 11-Jan-2024 8:05 AM EST
Higher viral load during HIV infection can shape viral evolution
Oxford University Press

A new paper in Molecular Biology and Evolution, published by Oxford University Press, finds that HIV populations in people with higher viral loads also have higher rates of viral recombination.

Not for public release

This news release is embargoed until 8-Jan-2024 4:00 PM EST Released to reporters: 2-Jan-2024 9:05 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 8-Jan-2024 4:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 8-Jan-2024 7:05 AM EST
Appalachia acutely suffers from opioid addiction and substance abuse disorders. An accredited online curriculum aids frontline prescribers in combating the crisis
The Rothman Orthopaedic Institute Foundation for Opioid Research and Education

A Philadelphia-based non-profit foundation is combating the opioid addiction epidemic at the source by educating frontline allied health professionals on various aspects of the nation's opioid crisis, specifically in Pennsylvania and the Appalachian region.

Released: 4-Jan-2024 2:00 PM EST
Starting a family with the help of science: The latest research in Fertility
Newswise

Find the latest research and features on fertility in the Fertility News Source on Newswise.

       

Not for public release

This news release is embargoed until 18-Dec-2023 5:00 PM EST Released to reporters: 12-Dec-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 18-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Engaging heterosexual men more effectively could slash HIV infections in Uganda
Released: 9-Dec-2023 10:05 AM EST
Engaging heterosexual men more effectively could slash HIV infections in Uganda
Imperial College London

A study looking at 15 years of HIV transmission and suppression in Uganda reveals how closing gender gaps in treatment could slash infection rates.

Released: 7-Dec-2023 11:05 AM EST
Very Early Treatment of Newborns with HIV Could Result in Medication-Free Remission for Many Babies
Ann and Robert H. Lurie Children's Hospital of Chicago

An unexpectedly high percentage of children, who were born with HIV and started treatment within 48 hours of life, exhibit biomarkers by 2 years of age that may make them eligible to test for medication-free remission, according to a multinational study published in Lancet HIV.

Released: 5-Dec-2023 7:05 AM EST
Dose matters: HIV drug could prevent coronaviruses, study finds
University of Bristol

New research by the University of Bristol has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration. The findings could strengthen the arsenal of antiviral drugs available to combat current and future coronavirus outbreaks.

Not for public release

This news release is embargoed until 1-Dec-2023 5:05 AM EST Released to reporters: 24-Nov-2023 10:05 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2023 5:05 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: November Research Highlights
Released: 30-Nov-2023 11:05 AM EST
November Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: Eradicating HIV Will Take Collaborative Action and a Commitment to Curb TB Infections
Released: 29-Nov-2023 8:00 AM EST
Eradicating HIV Will Take Collaborative Action and a Commitment to Curb TB Infections
American Thoracic Society (ATS)

The COVID-19 pandemic hampered progress in fighting tuberculosis infections worldwide. Diverted funds meant that one of the world’s leading infectious killers caused 1.3 million deaths in 2022. TB is also the leading cause of death among those with HIV /AIDS worldwide. In 2022, 167,000 people died of HIV-associated TB.

Released: 28-Nov-2023 12:05 PM EST
Ending the HIV Epidemic May Require Addressing “Everyday” Discrimination
Rutgers University-New Brunswick

Latino sexual minority men who experience racial, ethnic and sexual prejudice are more likely to delay HIV testing, complicating efforts to end the more than 40-year epidemic, according to a new Rutgers study.

   

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 22-Nov-2023 12:05 PM EST
World AIDS Day: How Far We’ve Come and Where We Still Need to Go
Rutgers University-New Brunswick

Jeffrey Kwong, a professor at the Rutgers School of Nursing and a national HIV expert discusses the progress made and the challenges to overcome in ending AIDS by 2030.

Released: 22-Nov-2023 9:05 AM EST
Fighting AIDS: Why the goal is to diagnose HIV before symptoms appear
Mayo Clinic

HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immunodeficiency syndrome), can hide in the body for many years before symptoms appear.

Released: 22-Nov-2023 9:05 AM EST
A luta contra a AIDS: por que é importante detectar o HIV antes que os sintomas apareçam
Mayo Clinic

O HIV (vírus da imunodeficiência humana) que causa a AIDS (síndrome de imunodeficiência adquirida) pode ficar oculto no corpo por muitos anos antes da manifestação dos sintomas.

Released: 22-Nov-2023 9:05 AM EST
La lucha contra el SIDA: por qué el objetivo es detectar el VIH antes de que aparezcan los síntomas
Mayo Clinic

El VIH (virus de la inmunodeficiencia humana), el virus que causa el SIDA (síndrome de inmunodeficiencia adquirida), se puede esconder en el organismo durante muchos años antes de que aparezcan los síntomas.



close
2.51929